WHO grants emergency approval to India's COVAXIN
Corona Update International Latest

WHO grants emergency approval to India’s COVAXIN

The World Health Organization said on Wednesday it had approved the Covaxin for emergency use. It is a vaccine made by Indian Biotech to combat the epidemic coronavirus. News from AFP.

In a statement, the UN agency said: “The vaccine has been shown to be 8 per cent effective, using two doses four weeks apart. It’s easy for low- and middle-income countries to stockpile the vaccine. “

The first vaccine to be manufactured and manufactured entirely in India has been approved by the WHO.

Based on the inactivated coronavirus antigen, it is the eighth vaccine to eradicate the WHO-listed Covid-19. Other vaccines approved by the company include Pfizer / Bioentech, Moderna, Astrogeneca, Johnson & Johnson, Sinopharma and Synovac.

In this case, the WHO’s approval of emergency use could strengthen the international recognition of vaccines.

They also authorize the use of these vaccines through various UN agencies and the Coronavirus International Coalition for Coronavirus.

Related posts

Awami League’s Peace and Development Rally in Dhaka on Saturday

engmtnews

UN chief says Russian move a ‘violation’ of Ukraine sovereignty

engmtnews

AI will Play an Important Role in Students’ Future Skills Acquisition

Zayed Nahin

Leave a Comment